Coherus Oncology Inc (NASDAQ: CHRS) kicked off on Tuesday, up 5.22% from the previous trading day, before settling in for the closing price of $1.34. Over the past 52 weeks, CHRS has traded in a range of $0.71-$1.89.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -27.36%. While this was happening, its average annual earnings per share was recorded -714.73%. With a float of $102.90 million, this company’s outstanding shares have now reached $116.24 million.
Coherus Oncology Inc (CHRS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Coherus Oncology Inc is 14.86%, while institutional ownership is 41.98%. The most recent insider transaction that took place on May 23 ’25, was worth 73,881. In this transaction Director of this company sold 99,988 shares at a rate of $0.74, taking the stock ownership to the 0 shares.
Coherus Oncology Inc (CHRS) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.28 earnings per share (EPS), lower than consensus estimate (set at -0.13) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -714.73% per share during the next fiscal year.
Coherus Oncology Inc (NASDAQ: CHRS) Trading Performance Indicators
Take a look at Coherus Oncology Inc’s (CHRS) current performance indicators. Last quarter, stock had a quick ratio of 1.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.59, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Coherus Oncology Inc (CHRS)
The latest stats from [Coherus Oncology Inc, CHRS] show that its last 5-days average volume of 0.69 million was inferior to 1.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 46.84%.
During the past 100 days, Coherus Oncology Inc’s (CHRS) raw stochastic average was set at 55.56%, which indicates a significant decrease from 73.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0777 in the past 14 days, which was lower than the 0.0978 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3938, while its 200-day Moving Average is $1.1328. Now, the first resistance to watch is $1.4633. This is followed by the second major resistance level at $1.5167. The third major resistance level sits at $1.5733. If the price goes on to break the first support level at $1.3533, it is likely to go to the next support level at $1.2967. Assuming the price breaks the second support level, the third support level stands at $1.2433.
Coherus Oncology Inc (NASDAQ: CHRS) Key Stats
The company with the Market Capitalisation of 170.43 million has total of 120,871K Shares Outstanding. Its annual sales at the moment are 266,960 K in contrast with the sum of 28,510 K annual income. Company’s last quarter sales were recorded 11,570 K and last quarter income was -35,530 K.
